Business, energy, technology, markets and global industry news from Business News Today

Kenvue Brands LLC

PharmaDeviceNews Kenvue Brands LLC
FDA approval of Tylenol with Naproxen introduces the first over-the-counter fixed-dose combination of acetaminophen and naproxen sodium for up to 12-hour pain relief in the United States. Representative image.
Pharma & Biotech

Kenvue wins FDA approval for first OTC acetaminophen and naproxen sodium combination

FDA approval gives Kenvue a 12-hour Tylenol and naproxen product, but safety warnings and retail execution will shape its commercial impact.

Read More